Robot-Assisted Surgery for Gastroesophageal Cancers is Transforming Patient Outcomes

A world leader in robot-assisted surgery (RAS), Roswell Park has treated more than 6,600 patients with this technique since 2004. RAS has led to shorter hospital stays, faster recovery and reduced pain for patients with many types of cancer: bladder, colorectal, gynecologic, head and neck, kidney and prostate. And it is routinely used for esophageal, stomach, and pancreatic cancer surgery. Now, thanks to the pioneering work of Moshim Kukar, MD, FACS, Department of Surgical Oncologyand his Roswell Park team, RAS is also the standard of care for eligible patients with gastroesophageal junction cancers. Roswell Park surgeons have performed more than 100 such procedures—one of the largest volumes at a U.S. center—and Dr. Kukar and his colleagues are helping advance the procedure regionally and nationally.

Created by

Roswell Park Comprehensive Cancer Center

Related Presenters

Moshim Kukar, MD

Moshim Kukar, MD

Vice Chair, Surgical Oncology
Chief, UGI, HPB and Endocrine Surgery
Program Director, Complex General Surgical Oncology Fellowship
Associate Professor of Oncology

Minimally invasive and robotic surgery for tumors of the esophagus, stomach, pancreas, liver, colon and rectum
Management of endocrine cancers of the thyroid, parathyroid and adrenal gland